Likely for chronic use
Does not engage the GH receptor's growth-promoting / glucose pathways in the same manner as intact GH
All interventions were dosed at the highest recommended daily doses, as per the PIONEER 2, 3, and 4 trial protocols
PT-141 is a powerful part of that journey, but it works best as part of a comprehensive, personalized treatment plan
The CCK8 assay was used to detect the proliferative capacity of the cells, MIA PaCa-2 and PANC-1 were spread in 96-well plates at 1500 cells/well, and then transfected after incubation for 24 hours (at this time it was 0 h), About 10 L of CCK8 (TargetMol, USA) solution was added to the 96-well at 24, 48 and 72 h after transfection and cells were incubated in 37 C for 2 h
Learn more about how personalized GLP-1 injections are structured to match individual tolerance